Printer Friendly
The Free Library
4,484,057 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bold aim in stroke: spare the brain.


Doctors of stroke patients were once so hampered by the lack of a remedy that they served mainly as "guides on a tragic journey," as one physician put it. Now, a newly available drug promises to change that-and health authorities have proposed a national strategy to speed patients into treatment in an effort to limit brain damage.

"The goal is to change the paradigm for the treatment of stroke in this country," Zach W. Hall, director of the National Institute of Neurological Disorders and Stroke (NINDS NINDS - National Institute of Neurological Disorders and Stroke) in Bethesda, Md., told members of 50 medical groups meeting in Arlington, Va., last week to draft the plan.

The drug is tissue plasminogen activator plasminogen activator /plas·min·o·gen ac·ti·va·tor/ (ak´ti-va?tor) see under activator., tPA, which dissolves blood clots. Developed by Genentech of South San Francisco, Calif., the intravenous drug has been used for 9 years to treat people having heart attacks. In June, the Food and Drug Administration approved a low-dose version for people suffering from strokes caused by clots that obstruct blood flow to the brain.

Trade-named Activase, tPA is effective only against these so-called ischemic strokes; it cannot help someone with a stroke caused by a hemorrhage. Since 80 percent of the 500,000 strokes that occur each year in the United States are ischemic, however, tPA could save thousands of people from paralysis and dependence on others.

A blood clot that causes ischemic stroke forms elsewhere in the body before breaking loose and traveling to the proximal cerebral artery
1. An artery that is one of two terminal branches of the internal carotid artery, divided into two parts and supplying the branches to the thalamus and corpus striatum and to the cortex of the medial parts of the frontal and parietal lobes.
2. An artery that is one of two terminal branches of the internal carotid artery, divided into three parts and supplying the perforating branches to the internal capsule, thalamus, and corpus striatum, the
. There, it cuts off blood flowing to the nerve centers that control speech and movement, causing weakness or numbness of the face or limbs, impaired vision, slurred speech, and unsteadiness.

Doctors must begin treating stroke victims within 3 hours in order to restore blood flow. The new strategy begins with a publicity campaign to ensure that anyone who experiences or witnesses a stroke knows what symptoms to look for. Other key elements include quick transportation to the hospital, rapid diagnosis using a CT scan of the brain, treatment with tPA, and rehabilitation.

"Brain cells are dying each minute after a stroke occurs-time equals brain," said John R. Marler, the NINDS medical officer who voiced jubilation that doctors would no longer have to serve merely as guides for patients descending into debility debility /de·bil·i·ty/ (de-bil´i-te) asthenia.

de·bil·i·ty (d-bl
. Marler supervised a multicenter trial showing that 12 percent of patients given tPA quickly reverted to normal. Six percent of the patients who got tPA suffered hemorrhaging, however, and had to forgo the treatment.

Just 4,000 stroke patients have been treated with the drug since it was approved, said Paul Laland, a Genentech spokesman. Doctors would like to extend treatment to 40,000 people by the end of next year.

The drug costs $2,200 per treatment, but this figure is a fraction of the $30,000 annual cost of sustaining one stroke patient in a nursing home.

Most hospitals have stocks of tPA on hand to treat heart attack patients, who get a higher dose. The new strategy, to be released in a month through the groups that attended the meeting, would also recommend that all hospitals have a CT scanner available and a stroke "code team" of trained doctors, nurses, and technicians on call around the clock.

The new procedures don't guarantee that treatment will reach most patients. Just 10 to 15 percent of hospitals now have stroke protocols. Although tPA has been available for nearly a decade, fewer than 35 percent of heart attack patients receive it.

James C. Grotta of the University of Texas Medical School in Houston objected that the new stroke guidelines fail to designate qualified hospitals as stroke centers. Consequently, paramedics won't know where to take patients, he said, and patients who expect tPA may not get it and "will be upset."

William G. Barsan of the University of Michigan Medical Center in Ann Arbor said the guidelines "rely on primary physicians to send the patient to the right place."
COPYRIGHT 1996 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:guidelines for using tissue plasminogen activator in treatment of stroke under development
Author:Sternberg, Steve
Publication:Science News
Date:Dec 21, 1996
Words:649
Previous Article:Aerogel films as electronic insulators. (nanoporous silica gel films could protect chip components from one another)(Materials Science)(Brief Article)
Next Article:Master pianists mature well with practice. (expert pianists can prevent age-related declines in performances through intensive practice)(Brief...
Topics:



Related Articles
Chilled brains: hibernating animals may hold clues to novel stroke treatments.(Cover Story)
Stroke drug reveals a dark side. (research shows tissue plasminogen activator may kill brain cells while dissolving blood clots)(Brief Article)
Stroke rescue: can cells injected into the brain reverse paralysis?(includes related information on preparing the cells to be injected)(Cover Story)
Compound in bat saliva may aid stroke patients. (Nifty Spittle).
The 5 Ps of acute ischemic stroke treatment: parenchyma, pipes, perfusion, penumbra, and prevention of complications. (Featured CME Topic:...
Management of acute stroke. (Featured CME Topic: Stroke).(medical research; includes symptoms tables and related article "Key Points")
Vampire spit gives strokes a licking.(Biomedicine)(Vampire bat saliva can aid stroke treatment)(Brief Article)
Primary stroke center: basic components and recommendations.(Review Article)(medical research)(includes related article "Key Points")
THROMBOGENICS STARTS PHASE IIA OF MICROPLASMIN FOR STROKE.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles